St Georges University NHS Foundation Trust Report issue

Foundation Phase 2

Organization Overview

First Clinical Trial
2016
NCT04380467
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Giovanni Franchin, M.D, Ph.D | St Georges University NHS Foundation Trust

Active Ingredients

Drugs in Phase 2 Trials (1)

pf-06650833 (1 trial)

Drugs in Other Trials (1)

vitamin d3 (1 trial)

Indications

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 2